Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Shekhtman

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
JHEP Reports : Innovation in Hepatology|April 16, 2025
Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytesLouis Shekhtman, Yuji Ishida, Masataka Tsuge, et al.
Science Translational Medicine|July 13, 2018
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug usersMarian Major, Alexander Gutfraind, Louis Shekhtman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
Multiple metastable network states in urban trafficGuanwen Zeng, Jianxi Gao, Louis Shekhtman, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasicStephanie Maya, Leeor Hershkovich, E Fabian Cardozo-Ojeda, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populationsLouis Shekhtman, Scott J Cotler, Elisabetta Degasperi, et al.
Scientific Reports|May 14, 2020
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAgLouis Shekhtman, Scott J Cotler, Leeor Hershkovich, et al.
Mbio|July 12, 2023
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasicStephanie Maya, Leeor Hershkovich, E Fabian Cardozo-Ojeda, et al.
Arxiv|June 12, 2026
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutionsAdquate Mhlanga, Louis Shekhtman, Ashish Goyal, et al.
Elife|November 3, 2021
Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearanceLouis Shekhtman, Miquel Navasa, Natasha Sansone, et al.
Scientific Reports|May 21, 2026
Early hepatitis B and delta virus kinetics in patients undergoing liver transplantationSara Battistella, Anna Pocurull, Thais Leonel, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
JHEP Reports : Innovation in Hepatology|April 16, 2025
Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytesLouis Shekhtman, Yuji Ishida, Masataka Tsuge, et al.
Science Translational Medicine|July 13, 2018
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug usersMarian Major, Alexander Gutfraind, Louis Shekhtman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
Multiple metastable network states in urban trafficGuanwen Zeng, Jianxi Gao, Louis Shekhtman, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasicStephanie Maya, Leeor Hershkovich, E Fabian Cardozo-Ojeda, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populationsLouis Shekhtman, Scott J Cotler, Elisabetta Degasperi, et al.
Scientific Reports|May 14, 2020
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAgLouis Shekhtman, Scott J Cotler, Leeor Hershkovich, et al.
Mbio|July 12, 2023
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasicStephanie Maya, Leeor Hershkovich, E Fabian Cardozo-Ojeda, et al.
Arxiv|June 12, 2026
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutionsAdquate Mhlanga, Louis Shekhtman, Ashish Goyal, et al.
Elife|November 3, 2021
Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearanceLouis Shekhtman, Miquel Navasa, Natasha Sansone, et al.
Scientific Reports|May 21, 2026
Early hepatitis B and delta virus kinetics in patients undergoing liver transplantationSara Battistella, Anna Pocurull, Thais Leonel, et al.
Pageof 3